Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Other Non Operating Income (2023 - 2025)

Volitionrx's Other Non Operating Income history spans 3 years, with the latest figure at -$1.5 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 537.06% year-over-year to -$1.5 million; the TTM value through Dec 2025 reached -$1.2 million, down 194.97%, while the annual FY2025 figure was -$1.8 million, 657.36% down from the prior year.
  • Other Non Operating Income reached -$1.5 million in Q4 2025 per VNRX's latest filing, down from $304443.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $304443.0 in Q3 2025 to a low of -$1.5 million in Q4 2025.
  • Average Other Non Operating Income over 3 years is -$125184.2, with a median of $6354.0 recorded in 2023.
  • The largest YoY upside for Other Non Operating Income was 151.53% in 2025 against a maximum downside of 537.06% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at $60776.0 in 2023, then tumbled by 483.4% to -$233015.0 in 2024, then plummeted by 537.06% to -$1.5 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Other Non Operating Income are -$1.5 million (Q4 2025), $304443.0 (Q3 2025), and -$16263.0 (Q2 2025).